Dexetimide
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | N04AA08 (WHO) |
Identifiers | |
|
|
CAS Number | 21888-98-2 |
PubChem (CID) | 30843 |
IUPHAR/BPS | 354 |
DrugBank | DB08997 |
ChemSpider | 28615 |
UNII | 43477QYX3D |
KEGG | D03711 |
ChEMBL | CHEMBL1908364 |
Chemical and physical data | |
Formula | C23H26N2O2 |
Molar mass | 362.465 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(what is this?) (verify) |
Dexetimide (brand name Tremblex) is a piperidine anticholinergic. It is a muscarinic antagonist that is used to treat drug induced parkinsonism. Dexetimide was discovered at Janssen Pharmaceutica in 1968.[1][2]
References[edit]
- ^ Dom, R.; Van Lommel, R.; Baro, F. (1971). "A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent". Acta Psychiatrica Scandinavica. 47 (4): 399–410. doi:10.1111/j.1600-0447.1971.tb03697.x. PMID 4947805.
- ^ Huygens, H.; Vereecken, J. L.; Tanghe, A. (1973). "Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action". Psychiatria, neurologia, neurochirurgia. 76 (4): 251–259. PMID 4581374.
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |